(Q40343208)

English

Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections

scientific article published on 17 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections (English)

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Mycobacterium tuberculosis

0 references

0 references

Christian Giske

5

object named as

C G Giske

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

author name string

P Juréen

1

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

K Angeby

2

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

E Sturegård

3

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

E Chryssanthou

4

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

J Werngren

6

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

M Nordvall

7

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

A Johansson

8

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

G Kahlmeter

9

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

S Hoffner

10

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

T Schön

11

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

language of work or name

0 references

publication date

17 March 2010

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

48

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

5

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

1853-1858

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Multidrug-resistant and extensively drug-resistant tuberculosis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Drug-susceptibility testing in tuberculosis: methods and reliability of results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Therapeutic drug monitoring in the treatment of tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Ethambutol and viomycin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

22 September 2017

Qualitative and quantitative drug-susceptibility tests in mycobacteriology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

15 June 2018

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2863855

20 August 2018

Is second-line anti-tuberculosis drug susceptibility testing reliable?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20237102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromatographic analysis of antituberculosis drugs in biological samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/20237102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/20237102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.00240-10

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40343208&oldid=1895763226"